Recall Issued For Allergan Textured Breast Implant After Being Tied To Rare Cancer
WASHINGTON (AP) -- Medical device maker Allergan Inc. is recalling a type of breast implant linked to a rare form of cancer.
The company Wednesday announced a worldwide recall of implants with a textured surface.
The U.S. Food and Drug Administration said it called for the removal after new information showed Allergan's Biocell breast implants account for a disproportionate share of rare lymphoma cases. The move follows similar bans by regulators in France, Australia and Canada.
The FDA is not recommending women with the implants have them removed if they are not experiencing problems.
- For more information on the recall, visit the FDA's website at this link.
The recalled implants feature a textured surface designed to prevent slippage and to minimize scar tissue. Such models account for just 5% of the U.S. market.
Most U.S. breast implants are smooth.
Visit CBS News for more information on this recall.
(© Copyright 2019 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)
